Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

The dynamic proteome of influenza A virus infection identifies M segment splicing as a host range determinant.

Bogdanow B, Wang X, Eichelbaum K, Sadewasser A, Husic I, Paki K, Budt M, Hergeselle M, Vetter B, Hou J, Chen W, Wiebusch L, Meyer IM, Wolff T, Selbach M.

Nat Commun. 2019 Dec 4;10(1):5518. doi: 10.1038/s41467-019-13520-8.

2.

A viral kinase counteracts in vivo restriction of murine cytomegalovirus by SAMHD1.

Deutschmann J, Schneider A, Gruska I, Vetter B, Thomas D, Kießling M, Wittmann S, Herrmann A, Schindler M, Milbradt J, Ferreirós N, Winkler TH, Wiebusch L, Gramberg T.

Nat Microbiol. 2019 Dec;4(12):2273-2284. doi: 10.1038/s41564-019-0529-z. Epub 2019 Sep 23.

PMID:
31548683
3.

Human cytomegalovirus overcomes SAMHD1 restriction in macrophages via pUL97.

Businger R, Deutschmann J, Gruska I, Milbradt J, Wiebusch L, Gramberg T, Schindler M.

Nat Microbiol. 2019 Dec;4(12):2260-2272. doi: 10.1038/s41564-019-0557-8. Epub 2019 Sep 23.

PMID:
31548682
4.

Activation of E2F-dependent transcription by the mouse cytomegalovirus M117 protein affects the viral host range.

Ostermann E, Loroch S, Qian Z, Sickmann A, Wiebusch L, Brune W.

PLoS Pathog. 2018 Dec 10;14(12):e1007481. doi: 10.1371/journal.ppat.1007481. eCollection 2018 Dec.

5.

Synthetic lethal mutations in the cyclin A interface of human cytomegalovirus.

Weisbach H, Schablowsky C, Vetter B, Gruska I, Hagemeier C, Wiebusch L.

PLoS Pathog. 2017 Jan 27;13(1):e1006193. doi: 10.1371/journal.ppat.1006193. eCollection 2017 Jan.

6.

Adenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication.

Krömmelbein N, Wiebusch L, Schiedner G, Büscher N, Sauer C, Florin L, Sehn E, Wolfrum U, Plachter B.

Viruses. 2016 Feb 2;8(2). pii: E37. doi: 10.3390/v8020037.

7.

PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry.

Eifler M, Uecker R, Weisbach H, Bogdanow B, Richter E, König L, Vetter B, Lenac-Rovis T, Jonjic S, Neitzel H, Hagemeier C, Wiebusch L.

PLoS Pathog. 2014 Nov 13;10(10):e1004514. doi: 10.1371/journal.ppat.1004514. eCollection 2014 Oct.

8.

Use of 5-ethynyl-2'-deoxyuridine labelling and flow cytometry to study cell cycle-dependent regulation of human cytomegalovirus gene expression.

Wiebusch L, Hagemeier C.

Methods Mol Biol. 2014;1119:123-32. doi: 10.1007/978-1-62703-788-4_9.

PMID:
24639222
9.

Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state.

Bogdanow B, Weisbach H, von Einem J, Straschewski S, Voigt S, Winkler M, Hagemeier C, Wiebusch L.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17510-5. doi: 10.1073/pnas.1312235110. Epub 2013 Oct 7.

10.

Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.

Oduro JD, Uecker R, Hagemeier C, Wiebusch L.

J Virol. 2012 Sep;86(17):9369-83. doi: 10.1128/JVI.07181-11. Epub 2012 Jun 20.

11.

The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression.

Montag C, Wagner JA, Gruska I, Vetter B, Wiebusch L, Hagemeier C.

J Virol. 2011 Nov;85(21):11409-21. doi: 10.1128/JVI.05028-11. Epub 2011 Aug 31.

12.

General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.

Zydek M, Uecker R, Tavalai N, Stamminger T, Hagemeier C, Wiebusch L.

J Gen Virol. 2011 Dec;92(Pt 12):2757-69. doi: 10.1099/vir.0.034173-0. Epub 2011 Aug 10.

PMID:
21832009
13.

Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.

Zydek M, Hagemeier C, Wiebusch L.

PLoS Pathog. 2010 Sep 9;6(9):e1001096. doi: 10.1371/journal.ppat.1001096.

14.

p53- and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress.

Wiebusch L, Hagemeier C.

Oncogene. 2010 Jun 17;29(24):3477-89. doi: 10.1038/onc.2010.99. Epub 2010 Apr 12.

PMID:
20383190
15.

Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells.

Wiebusch L, Neuwirth A, Grabenhenrich L, Voigt S, Hagemeier C.

J Virol. 2008 Oct;82(20):10188-98. doi: 10.1128/JVI.01212-08. Epub 2008 Jul 30.

16.

Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells.

Młynarczuk-Biały I, Roeckmann H, Kuckelkorn U, Schmidt B, Umbreen S, Gołab J, Ludwig A, Montag C, Wiebusch L, Hagemeier C, Schadendorf D, Kloetzel PM, Seifert U.

Cancer Res. 2006 Aug 1;66(15):7598-605.

17.

Human cytomegalovirus inactivates the G0/G1-APC/C ubiquitin ligase by Cdh1 dissociation.

Wiebusch L, Bach M, Uecker R, Hagemeier C.

Cell Cycle. 2005 Oct;4(10):1435-9. Epub 2005 Oct 2.

PMID:
16138013
19.

Inhibition of human cytomegalovirus replication by small interfering RNAs.

Wiebusch L, Truss M, Hagemeier C.

J Gen Virol. 2004 Jan;85(Pt 1):179-84.

PMID:
14718633
20.

Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia.

Schroeder U, Bernt KM, Lange B, Wenkel J, Jikai J, Shabat D, Amir R, Huebener N, Niethammer AG, Hagemeier C, Wiebusch L, Gaedicke G, Wrasidlo W, Reisfeld RA, Lode HN.

Blood. 2003 Jul 1;102(1):246-53. Epub 2003 Mar 6.

PMID:
12623853
21.
22.
24.

Supplemental Content

Loading ...
Support Center